Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,173 | 10,367 | 6,368 | 3,165 | 1,143 |
| Depreciation Amortization | 435 | 2,225 | 1,293 | 729 | 417 |
| Income taxes - deferred | N/A | -702 | N/A | N/A | N/A |
| Accounts receivable | -290 | -494 | -1,542 | 7,354 | 776 |
| Other Working Capital | 5,563 | 1,389 | -2,707 | 8,094 | -3,627 |
| Other Operating Activity | 758 | 746 | 2,087 | -6,821 | -243 |
| Operating Cash Flow | $7,639 | $13,531 | $5,499 | $12,521 | $-1,534 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -380 | -2,979 | -1,910 | -1,209 | -880 |
| Net Acquisitions | N/A | -556 | N/A | N/A | N/A |
| Investing Cash Flow | $-380 | $-3,535 | $-1,910 | $-1,209 | $-880 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,217 | -1,058 | 8,446 | -506 | 846 |
| Debt Issued | N/A | 1,307 | 385 | 359 | 372 |
| Debt Repayment | -930 | -3,884 | -764 | -714 | -738 |
| Common Stock Issued | 132 | 587 | 559 | 209 | 185 |
| Other Financing Activity | -3,714 | -3,202 | -7,462 | -7,988 | -690 |
| Financing Cash Flow | $-6,729 | $-6,250 | $1,164 | $-8,640 | $-25 |
| Exchange Rate Effect | -232 | -395 | -508 | -944 | -100 |
| Beginning Cash Position | 10,922 | 7,571 | 7,570 | 7,570 | 7,570 |
| End Cash Position | 11,220 | 10,922 | 11,815 | 9,298 | 5,031 |
| Net Cash Flow | $298 | $3,351 | $4,245 | $1,728 | $-2,539 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,639 | 13,531 | 5,499 | 12,521 | -1,534 |
| Capital Expenditure | -380 | -3,109 | -1,910 | -1,368 | -1,036 |
| Free Cash Flow | 7,259 | 10,422 | 3,589 | 11,153 | -2,570 |